AtriCure, Inc.
ATRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $465 | $399 | $330 | $274 |
| % Growth | 16.5% | 20.8% | 20.4% | – |
| Cost of Goods Sold | $118 | $99 | $84 | $68 |
| Gross Profit | $348 | $300 | $246 | $206 |
| % Margin | 74.7% | 75.2% | 74.4% | 75% |
| R&D Expenses | $96 | $74 | $57 | $49 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $291 | $253 | $231 | $205 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$103 |
| Operating Expenses | $388 | $327 | $289 | $151 |
| Operating Income | -$40 | -$27 | -$43 | $55 |
| % Margin | -8.6% | -6.7% | -12.9% | 20.1% |
| Other Income/Exp. Net | -$4 | -$3 | -$4 | -$5 |
| Pre-Tax Income | -$44 | -$30 | -$46 | $50 |
| Tax Expense | $1 | $1 | $0 | $0 |
| Net Income | -$45 | -$30 | -$46 | $50 |
| % Margin | -9.6% | -7.6% | -14.1% | 18.3% |
| EPS | -0.95 | -0.66 | -1.02 | 1.11 |
| % Growth | -43.9% | 35.3% | -191.9% | – |
| EPS Diluted | -0.95 | -0.66 | -1.02 | 1.09 |
| Weighted Avg Shares Out | 47 | 46 | 46 | 45 |
| Weighted Avg Shares Out Dil | 47 | 46 | 46 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $4 | $2 | $0 |
| Interest Expense | $6 | $7 | $5 | $5 |
| Depreciation & Amortization | $19 | $15 | $12 | $10 |
| EBITDA | -$19 | -$8 | -$30 | $66 |
| % Margin | -4% | -2% | -8.9% | 24% |